These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32530086)

  • 1. Risk of pump thrombosis and stroke in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding.
    Szymanski TW; Weeks PA; Patel CJ; Jezovnik MK; Gulbis B; Nathan SS; Jumean MF; Radovancevic R; Kar B; Gregoric ID
    Artif Organs; 2020 Nov; 44(11):1171-1175. PubMed ID: 32530086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of gastrointestinal bleeding and pump thrombosis in patients receiving the INCOR LVAD system in the long-term follow-up.
    Iacovoni A; Centofanti P; Attisani M; Verde A; Terzi A; Senni M; Maiani M; Baronetto A; Livi U; Frigerio M; Rinaldi M
    Int J Artif Organs; 2015 Oct; 38(10):542-7. PubMed ID: 26541278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Aortic Stiffness Is Associated With Higher Rates of Stroke, Gastrointestinal Bleeding and Pump Thrombosis in Patients With a Continuous Flow Left Ventricular Assist Device.
    Rosenblum H; Pinsino A; Zuver A; Javaid A; Mondellini G; Ji R; Cockcroft JR; Yuzefpolskaya M; Garan AR; Shames S; Topkara VK; Takayama H; Takeda K; Naka Y; Mcdonnell BJ; Willey JZ; Colombo PC; Stöhr EJ
    J Card Fail; 2021 Jun; 27(6):696-699. PubMed ID: 33639317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
    Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
    J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous-flow left ventricular assist devices.
    Veasey TM; Floroff CK; Strout SE; McElray KL; Brisco-Bacik MA; Cook JL; Toole JM; Craig ML; Van Bakel AB; Meadows HB; Uber WE
    Artif Organs; 2019 Aug; 43(8):736-744. PubMed ID: 30868618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients.
    Lopilato AC; Doligalski CT; Caldeira C
    Artif Organs; 2015 Nov; 39(11):939-44. PubMed ID: 25912789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
    Mehra MR; Netuka I; Uriel N; Katz JN; Pagani FD; Jorde UP; Gustafsson F; Connors JM; Ivak P; Cowger J; Ransom J; Bansal A; Takeda K; Agarwal R; Byku M; Givertz MM; Bitar A; Hall S; Zimpfer D; Vega JD; Kanwar MK; Saeed O; Goldstein DJ; Cogswell R; Sheikh FH; Danter M; Pya Y; Phancao A; Henderson J; Crandall DL; Sundareswaran K; Soltesz E; Estep JD;
    JAMA; 2023 Dec; 330(22):2171-2181. PubMed ID: 37950897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Patel SR; Madan S; Saeed O; Algodi M; Luke A; Gibber M; Goldstein DJ; Jorde UP
    JACC Heart Fail; 2016 Dec; 4(12):962-970. PubMed ID: 27744088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy.
    Malone G; Abdelsayed G; Bligh F; Al Qattan F; Syed S; Varatharajullu P; Msellati A; Mwipatayi D; Azhar M; Malone A; Fatimi SH; Conway C; Hameed A
    J Anat; 2023 Jan; 242(1):29-49. PubMed ID: 35445389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices.
    Shah R; Qayed E
    South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events.
    Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS
    ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited Efficacy of Thrombolytics for Pump Thrombosis in Durable Left Ventricular Assist Devices.
    Seese L; Hickey G; Keebler M; Thoma F; Kilic A
    Ann Thorac Surg; 2020 Dec; 110(6):2047-2054. PubMed ID: 32348739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
    Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
    Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.
    Xanthopoulos A; Tryposkiadis K; Triposkiadis F; Fukamachi K; Soltesz EG; Young JB; Wolski K; Blackstone EH; Starling RC
    J Am Heart Assoc; 2020 Jul; 9(14):e015897. PubMed ID: 32648508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.